ASPIRIN VERSUS CLOPIDOGREL IN PATIENTS WITH ISCHEMIC STROKE- A COST AND EFFECTIVENESS COMPARISON FROM BEIJING MEDICAL INSURANCE DATABASE
Author(s)
Wen L1, Wu J2, Yang L1
1Peking University, Beijing, China, 2Bayer, Beijing, China
Presentation Documents
OBJECTIVES: To compare the cost and effectiveness of aspirin and clopidogrel in ischemic stroke(IS) patients from data of Beijing medical insurance database. METHODS: We randomly selected 10% of patients diagnosed as IS the first time during January 2012- December 2012 and then followed their inpatient records and prescription records to September 2013 from Beijing urban employees and residents medical insurance database. We divided these patients into 5 groups according to their drug utilization records during the observation period. Patients were divided into 5 groups according to the proportion of aspirin prescription by 100.0%, 60.1-99.9%, 40.0-60.0%, 0-39.9% and 0(clopidogrel only). We compared the rate of recurrences, cost of anti-platelet drugs and rate of hemorrhage events in different drug utilization groups. The Kruskal-Wallis test and Bartlett's test were used in the analysis. RESULTS:
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PCV18
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Cardiovascular Disorders